BRCA1 5083del19 Mutant Allele Selectively Up-Regulates Periostin Expression In vitro and In vivo

No abstract is available for this paper.

• Publication year

  2008

• Venue

  Clinical Cancer Research

• Publication date

  2008-11-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1158/1078-0432.CCR-07-5208PMID 18980973
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Periostin promotes invasiveness and resistance of pancreatic cancer cells to hypoxia-induced cell death: role of the β4 integrin and the PI3k pathway

  2007cited by this paper
• Periostin creates a tumor-supportive microenvironment in the pancreas by sustaining fibrogenic stellate cell activity.

  2007cited by this paper
• Periostin: novel diagnostic and therapeutic target for cancer.

  2007cited by this paper
• Specific changes in the proteomic pattern produced by the BRCA1-Ser1841Asn missense mutation.

  2007cited by this paper
• Periostin promotes invasion and anchorage-independent growth in the metastatic process of head and neck cancer.

  2006cited by this paper
• Missense mutations of BRCA1 gene affect the binding with p53 both in vitro and in vivo.

  2006cited by this paper
• Periostin is frequently overexpressed and enhances invasion and angiogenesis in oral cancer

  2006cited by this paper
• Human plasma N-glycoproteome analysis by immunoaffinity subtraction, hydrazide chemistry, and mass spectrometry.

  2005cited by this paper
• Optimized Normalization for Antibody Microarrays and Application to Serum-Protein Profiling*S

  2005cited by this paper
• Focused Review Series : BRCA 1 at 10 Years Since Discovery

  2004cited by this paper
• Acquired Expression of Periostin by Human Breast Cancers Promotes Tumor Angiogenesis through Up-Regulation of Vascular Endothelial Growth Factor Receptor 2 Expression

  2004cited by this paper
• Vascular Injury Induces Expression of Periostin: Implications for Vascular Cell Differentiation and Migration

  2004cited by this paper
• Elevated Serum Periostin Levels in Patients with Bone Metastases from Breast but not Lung Cancer

  2003cited by this paper
• Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case Series unselected for family history: a combined analysis of 22 studies.

  2003cited by this paper
• BRCA1 expression modulates chemosensitivity of BRCA1-defective HCC1937 human breast cancer cells

  2003cited by this paper
• A random variance model for detection of differential gene expression in small microarray experiments

  2003cited by this paper
• Expert Commentary.

  2002cited by this paper
• Diagnosis of multiple cancer types by shrunken centroids of gene expression

  2002cited by this paper
• Expression of the periostin mRNA level in neuroblastoma.

  2002cited by this paper
• Gene expression profiling predicts clinical outcome of breast cancer

  2002cited by this paper
• Periostin secreted by epithelial ovarian carcinoma is a ligand for alpha(V)beta(3) and alpha(V)beta(5) integrins and promotes cell motility.

  2002cited by this paper
• Periostin Secreted by Epithelial Ovarian Carcinoma Is a Ligand for V 3 and V 5 Integrins and Promotes Cell Motility 1

  2002cited by this paper
• [Serial analysis of gene expression].

  2002cited by this paper
• Characterization of 11 novel mutations in the X‐linked chronic granulomatous disease (CYBB gene)

  2001cited by this paper
• Tumorigenesis in mice carrying a truncating Brca1 mutation.

  2001cited by this paper
• Transcriptional regulation of the mismatch repair gene hMLH1.

  2001cited by this paper
• Serum level of the periostin, a homologue of an insect cell adhesion molecule, in thymoma patients.

  2001cited by this paper
• Prognostic significance of BRCA1 expression in Japanese sporadic breast carcinomas

  2001cited by this paper
• In silico prediction of protein-protein interactions in human macrophages

  2001cited by this paper
• Predicting the clinical status of human breast cancer by using gene expression profiles

  2001cited by this paper
• Serum level of the periostin, a homologue of an insect cell adhesion molecule, as a prognostic marker in nonsmall cell lung carcinomas

  2001cited by this paper
• Evidence of a founder mutation of BRCA1 in a highly homogeneous population from southern Italy with breast/ovarian cancer

  2001cited by this paper
• BRCA1 Effects on the Cell Cycle and the DNA Damage Response Are Linked to Altered Gene Expression*

  2000cited by this paper
• Molecular portraits of human breast tumours

  2000cited by this paper
• Differential gene expression between normal and tumor-derived ovarian epithelial cells.

  2000cited by this paper
• Analysing uncharted transcriptomes with SAGE.

  2000cited by this paper
• BRCA1: exploring the links to transcription.

  2000cited by this paper
• Targeting angiogenesis inhibits tumor infiltration and expression of the pro‐invasive protein SPARC

  2000cited by this paper
• BASC, a super complex of BRCA1-associated proteins involved in the recognition and repair of aberrant DNA structures.

  2000cited by this paper
• A public database for gene expression in human cancers.

  1999cited by this paper
• Identification and Characterization of a Novel Protein, Periostin, with Restricted Expression to Periosteum and Periodontal Ligament and Increased Expression by Transforming Growth Factor β

  1999cited by this paper
• Pathological prognostic factors in breast cancer.

  1999cited by this paper
• Induction of GADD45 and JNK/SAPK-dependent apoptosis following inducible expression of BRCA1.

  1999cited by this paper
• Distinctive gene expression patterns in human mammary epithelial cells and breast cancers.

  1999cited by this paper
• Transcriptional regulation of stromelysin-1 gene expression is altered during progression of mouse mammary epithelial cells from functionally normal to malignant.

  1999cited by this paper
• Identification and characterization of a novel protein, periostin, with restricted expression to periosteum and periodontal ligament and increased expression by transforming growth factor beta.

  1999cited by this paper
• A superfamily of conserved domains in DNA damage‐ responsive cell cycle checkpoint proteins

  1997cited by this paper
• Gene expression profiles in normal and cancer cells.

  1997cited by this paper
• Arrest of the cell cycle by the tumour-suppressor BRCA1 requires the CDK-inhibitor p21WAF1/CiPl

  1997cited by this paper
• Mutations and Polymorphisms in the familial early‐onset breast cancer (BRCA1) gene

  1996cited by this paper
• BRCA1 is a 220-kDa nuclear phosphoprotein that is expressed and phosphorylated in a cell cycle-dependent manner.

  1996cited by this paper
• Germ-line BRCA1 mutations in Jewish and non-Jewish women with early-onset breast cancer.

  1996cited by this paper
• Serial Analysis of Gene Expression

  1995cited by this paper
• Quantitative Monitoring of Gene Expression Patterns with a Complementary DNA Microarray

  1995cited by this paper
• A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1.

  1994cited by this paper
• Confirmation of BRCA1 by analysis of germline mutations linked to breast and ovarian cancer in ten families

  1994cited by this paper
• Osteoblast-specific factor 2: cloning of a putative bone adhesion protein with homology with the insect protein fasciclin I.

  1993cited by this paper
• pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long‐term follow‐up

  1991cited by this paper
• Missense mutations of BRCA 1 gene affect the binding with p 53 both in vitro and in vivo

  year unknowncited by this paper

• Role of solute carrier transporters in ovarian cancer (Review)

  2024cites this paper
• FTH1P3, a Novel H-Ferritin Pseudogene Transcriptionally Active, Is Ubiquitously Expressed and Regulated during Cell Differentiation

  2016cites this paper
• DJ-1 in Endometrial Cancer: A Possible Biomarker to Improve Differential Diagnosis Between Subtypes

  2014cites this paper
• Periostin and receptor activator of nuclear factor κ‐B ligand expression in allergic fungal rhinosinusitis

  2014cites this paper
• Clinical interpretation and implications of whole-genome sequencing.

  2014cites this paper
• Identification of H ferritin-dependent and independent genes in K562 differentiating cells by targeted gene silencing and expression profiling.

  2014cites this paper
• Polymorphic Repeat Length in the AIB1 Gene and Breast Cancer Risk in BRCA1 and BRCA2 Mutation Carriers: A Meta-Analysis of Observational Studies

  2013cites this paper
• Negative transcriptional regulation of the human periostin gene by YingYang-1 transcription factor.

  2011cites this paper
• Periostin, a matrix specific protein, is associated with proliferation and invasion of pancreatic cancer.

  2011cites this paper
• BRCA1 is required for hMLH1 stabilization following doxorubicin-induced DNA damage.

  2011cites this paper
• Quantitative proteomic profiling of matched normal and tumor breast tissues.

  2010cites this paper
• La périostine, un nouveau biomarqueur des métastases osseuses : développement d’un immunodosage et évaluation préclinique

  2010cites this paper
• BRCA1 16 years later: risk‐associated BRCA1 mutations and their functional implications

  2010cites this paper
• Novel Roles for 185delAG Mutant BRCA1 in Ovarian Cancer Pathology

  2010cites this paper
• The multifaceted role of periostin in tumorigenesis

  2009influential citation
• Identification of drug-resistance predictive genes in breast cancer neoadjuvant chemotherapy

  2009cites this paper